{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:00:58Z","timestamp":1790128858329,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002630","name":"Ewha Womans University (KR)","doi-asserted-by":"publisher","award":["1-2013-0469-001-1"],"award-info":[{"award-number":["1-2013-0469-001-1"]}],"id":[{"id":"10.13039\/501100002630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00784-016-1718-2","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T19:15:47Z","timestamp":1453403747000},"page":"2251-2258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw"],"prefix":"10.1007","volume":"20","author":[{"given":"Jin-Woo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Erika A.","family":"Landayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquiline Czar I.","family":"Tatad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2347-3516","authenticated-orcid":false,"given":"Sun-Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Rae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Ho","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"issue":"6","key":"1718_CR1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RG Russell","year":"2008","unstructured":"Russell RG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19(6):733\u2013759","journal-title":"Osteoporos Int"},{"issue":"4","key":"1718_CR2","first-page":"517","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, et al. (2002) Meta-analyses of therapies for postmenopausal osteoporosis. III Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis Endocr Rev 23(4):517\u2013523","journal-title":"III Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis Endocr Rev"},{"issue":"1","key":"1718_CR3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","volume":"49","author":"MR Allen","year":"2011","unstructured":"Allen MR, Burr DB (2011) Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don\u2019t know. Bone 49(1):56\u201365","journal-title":"Bone"},{"issue":"8","key":"1718_CR4","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1210\/jc.2007-2803","volume":"93","author":"M Visekruna","year":"2008","unstructured":"Visekruna M, Wilson D, McKiernan FE (2008) Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab 93(8):2948\u20132952","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1718_CR5","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90(3):1294\u20131301","journal-title":"J Clin Endocrinol Metab"},{"issue":"34","key":"1718_CR6","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","volume":"23","author":"A Bamias","year":"2005","unstructured":"Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, et al. (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23(34):8580\u20138587","journal-title":"J Clin Oncol"},{"issue":"6","key":"1718_CR7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","volume":"24","author":"A Badros","year":"2006","unstructured":"Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, et al. (2006) Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 24(6):945\u2013952","journal-title":"J Clin Oncol"},{"issue":"1","key":"1718_CR8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bone.2012.10.016","volume":"52","author":"J Schilcher","year":"2013","unstructured":"Schilcher J, Koeppen V, Ranstam J, Skripitz R, Micha\u00eblsson K, Aspenberg P (2013) Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls. Bone 52(1):389\u2013392","journal-title":"Bone"},{"issue":"2","key":"1718_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","volume":"47","author":"A Giusti","year":"2010","unstructured":"Giusti A, Hamdy NAT, Papapoulos SE (2010) Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case\/case series studies. Bone 47(2):169\u2013180","journal-title":"Bone"},{"issue":"13","key":"1718_CR10","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jama.2010.1360","volume":"304","author":"DE Sellmeyer","year":"2010","unstructured":"Sellmeyer DE (2010) Atypical fractures as a potential complication of long-term bisphosphonate therapy. Jama 304(13):1480\u20131484","journal-title":"Jama"},{"issue":"11","key":"1718_CR11","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, et al. (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 25(11):2267\u20132294","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1718_CR12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00784-009-0300-6","volume":"14","author":"S Hoefert","year":"2010","unstructured":"Hoefert S, Schmitz I, Tannapfel A, Eufinger H (2010) Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clin Oral Investig 14(3):271\u2013284","journal-title":"Clin Oral Investig"},{"issue":"5","key":"1718_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s002230010036","volume":"69","author":"J Li","year":"2001","unstructured":"Li J, Mashiba T, Burr DB (2001) Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage. Calcif Tissue Int 69(5):281\u2013286","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"1718_CR14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S8756-3282(00)00402-6","volume":"27","author":"SW Donahue","year":"2000","unstructured":"Donahue SW, Sharkey NA, Modanlou KA, Sequeira LN, Martin RB (2000) Bone strain and microcracks at stress fracture sites in human metatarsals. Bone 27(6):827\u2013833","journal-title":"Bone"},{"issue":"4","key":"1718_CR15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bone.2010.07.006","volume":"47","author":"BC Herman","year":"2010","unstructured":"Herman BC, Cardoso L, Majeska RJ, Jepsen KJ, Schaffler MB (2010) Activation of bone remodeling after fatigue: differential response to linear microcracks and diffuse damage. Bone 47(4):766\u2013772","journal-title":"Bone"},{"issue":"3","key":"1718_CR16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00774-003-0472-0","volume":"22","author":"RC Dai","year":"2004","unstructured":"Dai RC, Liao EY, Yang C, Wu XP, Jiang Y (2004) Microcracks: an alternative index for evaluating bone biomechanical quality. J Bone Miner Metab 22(3):215\u2013223","journal-title":"J Bone Miner Metab"},{"key":"1718_CR17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bone.2015.08.002","volume":"81","author":"C Acevedo","year":"2015","unstructured":"Acevedo C, Bale H, Gludovatz B, Wat A, Tang SY, Wang M, et al. (2015) Alendronate treatment alters bone tissues at multiple structural levels in healthy canine cortical bone. Bone 81:352\u2013363","journal-title":"Bone"},{"key":"1718_CR18","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B et al. (2014) 2014 AAOMS position paper on medication-related osteonecrosis of the jaw. American Association of Oral and Maxillofacial Surgeons. Available from http:\/\/www.aaoms.org\/index.php"},{"issue":"6","key":"1718_CR19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tripleo.2011.04.020","volume":"112","author":"G Subramanian","year":"2011","unstructured":"Subramanian G, Cohen HV, Quek SY (2011) A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide\u2019s potential role in its resolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(6):744\u2013753","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5 Suppl","key":"1718_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","volume":"67","author":"MR Allen","year":"2009","unstructured":"Allen MR, Burr DB (2009) The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 67(5 Suppl):61\u201370","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"1718_CR21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11914-010-0008-1","volume":"8","author":"SK Kumar","year":"2010","unstructured":"Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW, Sedghizadeh PP (2010) The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy. Curr Osteoporos Rep 8(1):40\u201348","journal-title":"Curr Osteoporos Rep"},{"issue":"6","key":"1718_CR22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1600-0714.2011.01125.x","volume":"41","author":"J Abtahi","year":"2012","unstructured":"Abtahi J, Agholme F, Sandberg O, Aspenberg P (2012) Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone. J Oral Pathol Med 41(6):494\u2013499","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"1718_CR23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrrheum.2011.181","volume":"8","author":"IR Reid","year":"2012","unstructured":"Reid IR, Cornish J (2012) Epidemiology and pathogenesis of osteonecrosis of the jaw. Nat Rev Rheumatol 8(2):90\u201396","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1718_CR24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00774-010-0162-7","volume":"28","author":"T Yoneda","year":"2010","unstructured":"Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, et al. (2010) Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis sSociety, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab 28(4):365\u2013383","journal-title":"J Bone Miner Metab"},{"key":"1718_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/cid.12297","author":"JW Kim","year":"2015","unstructured":"Kim JW, Cha IH, Kim SJ, Kim MR (2015) Biomarkers for bisphosphonate-related osteonecrosis of the jaw. Clin Implant Dent Relat Res. doi: 10.1111\/cid.12297","journal-title":"Clin Implant Dent Relat Res"},{"issue":"6","key":"1718_CR26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/sca.4950190605","volume":"19","author":"KM Nemati","year":"1997","unstructured":"Nemati KM (1997) Fracture analysis of concrete using scanning electron microscopy. Scanning 19(6):426\u2013430","journal-title":"Scanning"},{"key":"1718_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1402.089","volume":"1117","author":"RG Russell","year":"2007","unstructured":"Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, et al. (2007) Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117:209\u2013257","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"1718_CR28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","volume":"28","author":"T Mashiba","year":"2001","unstructured":"Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB (2001) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28(5):524\u2013531","journal-title":"Bone"},{"issue":"6","key":"1718_CR29","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1359\/JBMR.040126","volume":"19","author":"S Komatsubara","year":"2004","unstructured":"Komatsubara S, Mori S, Mashiba T, Li J, Nonaka K, Kaji Y, et al. (2004) Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib. J Bone Miner Res 19(6):999\u20131005","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1718_CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","volume":"40","author":"S Otto","year":"2012","unstructured":"Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Sturzenbaum S, et al. (2012) Bisphosphonate-related osteonecrosis of the jaws\u2014characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg 40(4):303\u2013309","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"1718_CR31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ctrv.2006.09.003","volume":"33","author":"AW Eckert","year":"2007","unstructured":"Eckert AW, Maurer P, Meyer L, Kriwalsky MS, Rohrberg R, Schneider D, et al. (2007) Bisphosphonate-related jaw necrosis\u2014severe complication in maxillofacial surgery. Cancer Treat Rev 33(1):58\u201363","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"1718_CR32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15(4):613\u2013620","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1718_CR33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bone.2006.04.028","volume":"39","author":"MR Allen","year":"2006","unstructured":"Allen MR, Iwata K, Phipps R, Burr DB (2006) Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone 39(4):872\u2013879","journal-title":"Bone"},{"issue":"3","key":"1718_CR34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00223-005-1295-x","volume":"77","author":"T Mashiba","year":"2005","unstructured":"Mashiba T, Hui S, Turner CH, Mori S, Johnston CC, Burr DB (2005) Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs. Calcif Tissue Int 77(3):180\u2013185","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1718_CR35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1359\/jbmr.090713","volume":"25","author":"MR Allen","year":"2010","unstructured":"Allen MR, Kubek DJ, Burr DB (2010) Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs. J Bone Miner Res 25(1):98\u2013105","journal-title":"J Bone Miner Res"},{"issue":"9","key":"1718_CR36","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83(9):1032\u20131045","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"1718_CR37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bone.2013.02.004","volume":"55","author":"B Ettinger","year":"2013","unstructured":"Ettinger B, Burr DB, Ritchie RO (2013) Proposed pathogenesis for atypical femoral fractures: lessons from materials research. Bone 55(2):495\u2013500","journal-title":"Bone"},{"issue":"3","key":"1718_CR38","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bone.2009.11.011","volume":"46","author":"S Gourion-Arsiquaud","year":"2010","unstructured":"Gourion-Arsiquaud S, Allen MR, Burr DB, Vashishth D, Tang SY, Boskey AL (2010) Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone 46(3):666\u2013672","journal-title":"Bone"},{"issue":"3","key":"1718_CR39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","volume":"41","author":"IR Reid","year":"2007","unstructured":"Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41(3):318\u2013320","journal-title":"Bone"},{"issue":"2","key":"1718_CR40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.oooo.2012.08.455","volume":"115","author":"PP Sedghizadeh","year":"2013","unstructured":"Sedghizadeh PP, Jones AC, LaVallee C, Jelliffe RW, Le AD, Lee P, et al. (2013) Population pharmacokinetic and pharmacodynamic modeling for assessing risk of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 115(2):224\u2013232","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"3","key":"1718_CR41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S8756-3282(98)00104-5","volume":"23","author":"V Bentolila","year":"1998","unstructured":"Bentolila V, Boyce TM, Fyhrie DP, Drumb R, Skerry TM, Schaffler MB (1998) Intracortical remodeling in adult rat long bones after fatigue loading. Bone 23(3):275\u2013281","journal-title":"Bone"},{"issue":"10","key":"1718_CR42","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","volume":"104","author":"LI Plotkin","year":"1999","unstructured":"Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104(10):1363\u20131374","journal-title":"J Clin Invest"},{"issue":"17","key":"1718_CR43","first-page":"3309","volume":"19","author":"S Rosini","year":"2015","unstructured":"Rosini S, Rosini S, Bertoldi I, Frediani B (2015) Understanding bisphosphonates and osteonecrosis of the jaw: uses and risks. Eur Rev Med Pharmacol Sci 19(17):3309\u20133317","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"1718_CR44","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bone.2004.06.001","volume":"35","author":"B Frediani","year":"2004","unstructured":"Frediani B, Spreafico A, Capperucci C, Chellini F, Gambera D, Ferrata P, et al. (2004) Long-term effects of neridronate on human osteoblastic cell cultures. Bone 35(4):859\u2013869","journal-title":"Bone"},{"issue":"2","key":"1718_CR45","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bone.2012.07.028","volume":"52","author":"OO Aruwajoye","year":"2013","unstructured":"Aruwajoye OO, Patel MK, Allen MR, Burr DB, Aswath PB, Kim HK (2013) Microcrack density and nanomechanical properties in the subchondral region of the immature piglet femoral head following ischemic osteonecrosis. Bone 52(2):632\u2013639","journal-title":"Bone"},{"issue":"4","key":"1718_CR46","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00784-009-0336-7","volume":"13","author":"MR Allen","year":"2009","unstructured":"Allen MR (2009) Studying the role of microcracks in the pathophysiology of BRONJ. Clin Oral Investig 13(4):481\u2013482 author reply 483-484","journal-title":"Clin Oral Investig"},{"issue":"2","key":"1718_CR47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1469-7580.2003.00213.x","volume":"203","author":"A Boyde","year":"2003","unstructured":"Boyde A (2003) The real response of bone to exercise. J Anat 203(2):173\u2013189","journal-title":"J Anat"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-016-1718-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1718-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:25:13Z","timestamp":1567535113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-016-1718-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1718"],"URL":"https:\/\/doi.org\/10.1007\/s00784-016-1718-2","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,22]]}}}